AC
ELV icon

Athanor Capital’s Elevance Health ELV Stock Holding History

Athanor Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,305
Closed -$740K – 884
2020
Q4 		$740K Sell
2,305
-2,853
-55% -$876K 0.02% 382
2020
Q3 		$1.39M Buy
+5,158
New +$1.39M 0.05% 185
2020
Q2 		– Sell
-5,212
Closed -$1.18M – 541
2020
Q1 		$1.18M Sell
5,212
-588
-10% -$160K 0.08% 97
2019
Q4 		$1.75M Sell
5,800
-100
-2% -$27.5K 0.08% 119
2019
Q3 		$1.42M Buy
+5,900
New +$1.62M 0.09% 90

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Athanor Capital's ELV Position: Q1 2021 in Review

Athanor Capital sold out of Elevance Health (ELV) in Q1 2021, closing a stake of 2,305 shares — an estimated $740K sold.

Athanor Capital first reported a position in ELV in Q3 2019 and held it in 5 quarters. The position peaked at $1.75M in Q4 2019. 1,211 funds tracked by Wall St. Rank hold ELV as of Q1 2021.

  • Athanor Capital reported no remaining Elevance Health position as of Q1 2021 after selling out during the quarter.
  • Athanor Capital sold 2,305 Elevance Health shares in Q1 2021, an estimated $740K.
  • Athanor Capital first reported a position in Elevance Health in Q3 2019 and held it in 5 quarters.
  • Athanor Capital's Elevance Health position peaked at $1.75M in Q4 2019.
  • 1,211 funds tracked by Wall St. Rank held Elevance Health as of Q1 2021.

Based on Athanor Capital's 13F filing for Q1 2021, filed 14 May 2021.